Document is current
Any future updates will be listed below
-
Authors
Errihani, Hassan
Berrada, Narjiss
El Bachiri, Meryem
Jouhadi, Hassan
Kabbaj, Omar
Bourhafour, Mouna
Benider, Abdellatif
Khouchani, Mouna
Belbaraka, Ghizlane
Acharki, Abdelkader
Samlali, Redouane
Upveja, Kunvar Harsh
- License Information
-
More Information
Article History
Received: 23 December 2024
Accepted: 7 April 2026
First Online: 28 April 2026
Declarations
:
: Patients provided informed consent to participate in the study and authorized the collection and processing of their clinical data before inclusion in the HERLife program. The study was conducted in accordance with the regulations of Morocco authorities. Ethics approval was obtained from FDA-certified ethics committees comité d’éthique pour la recherche biomédicale and Université Mohammed V de Rabat – Faculté de médecine et de Pharmacie de Rabat (approval number:46/20) and the National Control Commission for the Protection of Personal Data (CNDP) (approval number: A-R-S-184/2020), and Institutional leaders of the sites where the research was conducted.
: Not applicable.
: Kunvar Harsh Upveja is working as a full-term employee of Biocon Biologics Limited and other authors declare that they have no competing interests.
